Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
It's pretty obvious.
The masks would sell if they were available.
VK want lots for India and hasn't got them all yet.
The NHS probably wants lots too.
Any issue in making masks has been removed by getting rid of the dodgy Spanish machine and outsourcing to Volz.
The problem here IMHO is that the company has not kept upto speed with the increasing demand from all quarters for it's nano-particles. That's why they want Dr C to build an upgraded uber nano particle production line.
So whilst there may not have been enough nano particles to make all the masks they would have liked as quickly as they would have liked, those nano particles are going somewhere.
Take your pick:
-Filters being stockpiled for launch
-Nano 10-9
-Citrus Greening cure
-chili pepper / hydro farm fertiliser
-Something else on the horizon.
They just need to make sure wherever they are going they can monitise them soon.
GLA GYOR
Sharkie,
It is as it is . If Mr. Duffin had anything of significance to say, he would have said it in last week’s RNS.
To my mind, there are two issues regarding Nanosynth’s masks that need immediate clarification.
Firstly, the status of the Indian contract. Is there a mask manufacturing issue?, does the suppler lack the necessary funds?, or is it something else?
Secondly, an online seller claims that Nanosynth’s masks are being used by the DHSS? Immediate clarification of this would help to restore confidence.
The company is too quiet by far, and it is high time for Mr. Duffin to assert himself and make Nanosynth’s presence as a supplier of high quality masks felt both in the UK and elsewhere.
Regards and good wishes.
Sharkie, as I said before, going by the last rns, we should be getting an rns every 2 or 3 weeks. They have mentioned so much. Let’s see.
MORWENATRELAWNE.
There are already advanced air filtration systems in place which totally remove virus entities. The ones that I have looked at trap the entities and subsequently eradicate them using high energy ultraviolet radiation. My point here is that the simpler nano particle system conceived by Dr. Cave’s research group could be adapted for use in an existing system thus simplifying the process. Surely Dr. Cave must already be collaborating with air filtration specialist companies on this? Investors have been told that proof of concept has been established but no more than that.
Regards and good wishes.
Good morning Sharkie,
You are right in that the company has stagnated without significant news for too long. In his strategic update statement to shareholders last week, the CEO wrote about delivering value to shareholders In the short to medium term. No specific timeline has been issued. In my previous investor experience, this kind of time has been as long as 3 -6 months. Given that he has been kitchen sinking and re - organising the company for three months already, I would expect to hear something significant before the end of Q1 2022. That having been said, it is my opinion, which amounts to nothing if Mr. Duffin is as irresponsible as Dr. Cave in his promises? I am hopeful that this is not the case.
Regards and good wishes.
Quote from last week’s update:
Mark Duffin, CEO commented: "I am delighted to report that since joining the Company we have made rapid progress developing and beginning to implement our strategy which is designed to establish a firm foundation for the business. The Board is committed to generate shareholder value in the short to medium term. We will continue to keep stakeholders appraised as we achieve key milestones."
Interesting comments about Dr Cave. In regard to your last paragraph don't you imagine many of the large international companies are and have been working on air filtration for aircraft already?
Sharkie,
I will repeat my thoughts about Dr. Cave's prolific publications output. They add a great deal to his credibility as an academic in the nano-technology field , but sadly contribute little to Nanosynth's investment case as things stand.
A lot is said about Dr. Cave on this board, but how significant a presence is he in the Nanosynth boardroom?
United Guy corrected my misassumption when I wrongly stated that he was Nanosynth’s CSO? Apparently, he hasn’t taken up the position yet? This explains how he has the time to be a co-contributor to so many research papers at his University.
Research papers add to existing knowledge, but we cannot assume that they will lead to patentable products of any value to Nanosynth?
When Dr. Cave was a guest on a podcast earlier this year he gave the impression of being a likeable person. However the interview revealed no hard facts about the company or about its future development. Dr. Cave appears to be playing the minor celebrity act, which is fine if you have a well-defined marketable product and growing sales figures. The linear decline in share price this year shows that this is not the case yet, and that a lot of work remains to be done.
My hope as an investor is for imminent news about new contracts, and product development, perhaps with a similar concept to the mask anti virus technology applied to air filtration systems?
Regards and good wishes.
Oocanibe.
Thank you for your reply.
A lot is said about Dr. Cave on this board, but how significant a presence is he in the Nanosynth boardroom?
United Guy corrected my misassumption when I wrongly stated that he was Nanosynth’s CSO? Apparently, he hasn’t taken up the position yet? This explains how he has the time to be a co-contributor to so many research papers at his University.
Research papers add to existing knowledge, but we cannot assume that they will lead to patentable products of any value to Nanosynth?
When Dr. Cave was a guest on a podcast earlier this year he gave the impression of being a likeable person. However the interview revealed no hard facts about the company or about its future development. Dr. Cave appears to be playing the minor celebrity act, which is fine if you have a well defined marketable product and growing sales figures. The linear decline in share price this year shows that this is not the case yet, and that a lot of work remains to be done.
My hope as an investor is for imminent news about new contracts, and product development, perhaps with a similar concept to the mask anti virus technology applied to air filtration systems?
Regards and good wishes.
I hope some/any of this is right and there are things in the works... Currently a load down here (60+%). Getting to the point of cutting my losses at the moment - but the only thing stopping me is that there's more upside than downside currently (downside takes me to 0, but closer to that than break even)
Massively frustrating....
Just my opinion, DYOR
Cave and his team must be working hard on new materials..
Exellent stuff..
Deals going on to incorporate his magic materials.
World talk of manafacture..
Not to forget the science of nes products..
Nano Fertilizer sales ..
Update not far away to correct the last RNS .
Filtering is high on the uk government list of urgency...
Off to take my PCR test for travel .... MASKS ON
Happy Days castle ..
I'm not posting on here but I've had many conversations and emails exchanges over the year and let's just say only 1 thing he's told me has slightly happened and that's the india deal and look how we'll that has gone.
Your welcome Oocanibe ..
You may be correct, as I see it Dr Cave, is intellectual, but hasn't a clue about business, that's how TB got his greasy slimy hands into the pot.
What things did Dr Cave say that were a lies?
The guy likes TB and I believe stays in contact with him.
how can you say Dr C is a man of integrity the man has lied and lied oh and lied. He might be an intellectual but he has no integrity what so ever .
Dr cave should never of got involved with TB , such a great guy with vision mixing it up with a con artist, can taint his character, and the true believer's being mugged off...
Hi TLW (if I may be so bold to address you as such?)
I don't think Dr Cave has sold any of his shares...just like he said he wouldn't?
I don't understand the contents of the papers he has been involved in except the cataract one but I'm sure in due course Dr Cave will gladly talk (& dumb down) the contents of the papers for us all & reveal the amazing new avenues that they are exploring.
Yes, I'm a LTH, so far underwater that even the late great Jacques Cousteau would have trouble diving to....but I hold due to the amazing future prospects we have here & when Dr Cave said he was a man of integrity.....I did & still do believe he is!
TLWillaim, NNN said Dr Cave appointment as CSO was subject to agreement and shareholders would be updated in due course. I don't recall such an update so I think he has plenty of time for academic papers .
Oocanibe,
We are happy that Dr. Cave is prolific in his publishing output. He is evidently an accomplished academic. As a Nanosynth investor, i am more interested in how he is functioning as the company's CSO? He is also Nanosynth's major shareholder, and I trust that he is using his considerable skills, and patented technology, to develop new products to enable the company to grow above the current year-low MCap levels?
Regards and good wishes.
Thanks for posting this, Castlepaul13. It's a shame it hasn't been more discussed on this BB today!!
Journal article
DANILOVA, S., SORT, J., GRAVES, J.E., PELLICER, E., CAVE, G.W.V. and COBLEY, A., 2021. Electroless copper plating obtained by Selective Metallisation using a Magnetic Field (SMMF). Electrochimica Acta, 389: 138763. ISSN 0013-4686
HABRA, K., MCARDLE, S.E.B., MORRIS, R.H. and CAVE, G.W.V., 2021. Synthesis and functionalisation of superparamagnetic nano-rods towards the treatment of glioblastoma brain tumours. Nanomaterials, 11 (9): 2157. ISSN 2079-4991
OH, S., CAVE, G. and LU, C., 2021. Vitamin B12 (cobalamin) and micronutrient fortification in food crops using nanoparticle technology. Frontiers in Plant Science, 12: 668819. ISSN 1664-462X
MEKAPOTHULA, S., WONANKE, A.D.D., ADDICOAT, M.A., BOO****, D.J., WALLIS, J.D. and CAVE, G.W.V., 2021. Supramolecular chromatographic separation of C60 and C70 fullerenes: flash column chromatography vs. high pressure liquid chromatography. International Journal of Molecular Sciences, 22 (11): 5726. ISSN 1661-6596
HANAFY, B.I., CAVE, G.W.V., BARNETT, Y. and PIERSCIONEK, B.K., 2021. Nanoceria prevents glucose-induced proteinglycation in eye lens cells. Nanomaterials, 11 (6), p. 1473.
MEKAPOTHULA, S., WONANKE, A.D.D., ADDICOAT, M.A., WALLIS, J.D., BOO****, D.J. and CAVE, G.W.V., 2021. A supramolecular cavitand for selective chromatographic separation of peptides using LC-MS/MS: a combined in silico and experimental approach. New Journal of Chemistry, 45 (1), pp. 141-146. ISSN 1144-0546
HELAL, M.A., ABDEL-GAWAD, A.M., KANDIL, O.M., KHALIFA, M.M.E., CAVE, G.W.V., MORRISON, A.A., BARTLEY, D.J. and ELSHEIKHA, H.M., 2020. Nematocidal effects of a coriander essential oil and five pure principles on the infective larvae of major ovine gastrointestinal nematodes in vitro. Pathogens, 9 (9): 740. ISSN 2076-0817
ALKHTIB, A., SCHOLEY, D., CARTER, N., CAVE, G.W.V., HANAFY, B.I., KEMPSTER, S.R.J., MEKAPOTHULA, S., ROXBOROUGH, E.T. and BURTON, E.J., 2020. Bioavailability of methionine-coated zinc nanoparticles as a dietary supplement leads to improved performance and bone strength in broiler chicken production. Animals, 10 (9): 1482.
ABDURAKMAN, E., BENCSIK, M., CAVE, G.W.V., HOAD, C.L., MCGOWAN, S., FAIRHURST, D.J., MAJOR, G., GOWLAND, P.A. and BOWTELL, R., 2020. Design and testing of microbubble-based MRI contrast agents for gastric pressure measurement. Magnetic Resonance in Medicine, 83 (3), pp. 1096-1108. ISSN 0740-3194
CAVE, G., BARNETT, Y., PIERSCIONEK, B. and HANAFY, B., 2020. Treatment of human lens epithelium with high levels of nanoceria leads to reactive oxygen species mediated apoptosis. Molecules, 25 (3): 441. ISSN 1420-3049
MEKAPOTHULA, S., ADDICOAT, M.A., BOO****, D.J., WALLIS, J.D., CRAGG, P.J. and CAVE, G.W.V., 2020. Silica bound co-pillar[4+1]arene as a novel supramolecular stationary phase. Chemical Communications. ISSN 1359-7345
Gareth Cave
Jump to: Journal article | Conference contribution | Patent/Published patent application
Number of items: 71.
Journal article
DANILOVA, S., SORT, J., GRAVES, J.E., PELLICER, E., CAVE, G.W.V. and COBLEY, A., 2021. Electroless copper plating obtained by Selective Metallisation using a Magnetic Field (SMMF). Electrochimica Acta, 389: 138763. ISSN 0013-4686
HABRA, K., MCARDLE, S.E.B., MORRIS, R.H. and CAVE, G.W.V., 2021. Synthesis and functionalisation of superparamagnetic nano-rods towards the treatment of glioblastoma brain tumours. Nanomaterials, 11 (9): 2157. ISSN 2079-4991
OH, S., CAVE, G. and LU, C., 2021. Vitamin B12 (cobalamin) and micronutrient fortification in food crops using nanoparticle technology. Frontiers in Plant Science, 12: 668819. ISSN 1664-462X
MEKAPOTHULA, S., WONANKE, A.D.D., ADDICOAT, M.A., BOO****, D.J., WALLIS, J.D. and CAVE, G.W.V., 2021. Supramolecular chromatographic separation of C60 and C70 fullerenes: flash column chromatography vs. high pressure liquid chromatography. International Journal of Molecular Sciences, 22 (11): 5726. ISSN 1661-6596
HANAFY, B.I., CAVE, G.W.V., BARNETT, Y. and PIERSCIONEK, B.K., 2021. Nanoceria prevents glucose-induced proteinglycation in eye lens cells. Nanomaterials, 11 (6), p. 1473.
MEKAPOTHULA, S., WONANKE, A.D.D., ADDICOAT, M.A., WALLIS, J.D., BOO****, D.J. and CAVE, G.W.V., 2021. A supramolecular cavitand for selective chromatographic separation of peptides using LC-MS/MS: a combined in silico and experimental approach. New Journal of Chemistry, 45 (1), pp. 141-146. ISSN 1144-0546
HELAL, M.A., ABDEL-GAWAD, A.M., KANDIL, O.M., KHALIFA, M.M.E., CAVE, G.W.V., MORRISON, A.A., BARTLEY, D.J. and ELSHEIKHA, H.M., 2020. Nematocidal effects of a coriander essential oil and five pure principles on the infective larvae of major ovine gastrointestinal nematodes in vitro. Pathogens, 9 (9): 740. ISSN 2076-0817
ALKHTIB, A., SCHOLEY, D., CARTER, N., CAVE, G.W.V., HANAFY, B.I., KEMPSTER, S.R.J., MEKAPOTHULA, S., ROXBOROUGH, E.T. and BURTON, E.J., 2020. Bioavailability of methionine-coated zinc nanoparticles as a dietary supplement leads to improved performance and bone strength in broiler chicken production. Animals, 10 (9): 1482.
ABDURAKMAN, E., BENCSIK, M., CAVE, G.W.V., HOAD, C.L., MCGOWAN, S., FAIRHURST, D.J., MAJOR, G., GOWLAND, P.A. and BOWTELL, R., 2020. Design and testing of microbubble-based MRI contrast agents for gastric pressure measurement. Magnetic Resonance in Medicine, 83 (3), pp. 1096-1108. ISSN 0740-3194
CAVE, G., BARNETT, Y., PIERSCIONEK, B. and HANAFY, B., 2020. Treatment of human lens epithelium with high levels of nanoceria leads to reactive oxygen species mediated apoptosis. Molecules, 25 (3): 441. ISSN 1420-3049
MEKAPOTHULA, S., ADDICOAT, M.A., BOO****, D.J., WALLIS, J.D., CRAGG, P.J. and CAVE, G.W.V., 2020. Silica bound co-pillar[4+1]arene as a novel supramolecular stationary phase. Chemical Communications. ISSN 1359-7345
A